{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:35:06Z","timestamp":1789011306324,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1I1A1A01062561"],"award-info":[{"award-number":["NRF-2019R1I1A1A01062561"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Accurate detection of cytogenetic abnormalities has become more important for improving risk-adapted treatment strategies in multiple myeloma (MM). However, precise cytogenetic testing by fluorescence in situ hybridization (FISH) is challenged by the dilution effect of bone marrow specimens and poor growth of plasma cells ex vivo. It has been suggested that FISH should be performed in combination with plasma cell enrichment strategies. We examined cytogenetic abnormalities in newly diagnosed MM and compared the efficacy of three different enrichment modalities for FISH: direct FISH (n\u2009=\u2009137), fluorescence immunophenotyping and interphase cytogenetics as a tool for the investigation of neoplasms (FICTION) technique (n\u2009=\u2009224), and a plasma cell sorting FISH with fluorescence-activated cell sorter (FACS) (n\u2009=\u2009132). FISH disclosed cytogenetic abnormalities in 38.0% of samples by direct FISH, 56.3% by FICTION, and 95.5% by FACS-FISH, and the percentage of cells with abnormal signals detected by FISH was significantly higher by FACS-FISH than direct FISH or FICTION. Our results suggest that the efficacy of FISH is dependent on the plasma cell enrichment modalities and reveal that plasma cell sorting FISH with FACS enables better detection of cytogenetic abnormalities in diagnostic MM samples.<\/jats:p>","DOI":"10.1038\/s41598-022-11676-w","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T13:03:13Z","timestamp":1652878993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cytogenetic testing by fluorescence in situ hybridization is improved by plasma cell sorting in multiple myeloma"],"prefix":"10.1038","volume":"12","author":[{"given":"Jihye","family":"Ha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunsoo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taek Gyu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeam","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haerim","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Eun","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June-Won","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Rak","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"11676_CR1","doi-asserted-by":"publisher","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","volume":"15","author":"SV Rajkumar","year":"2014","unstructured":"Rajkumar, S. V. et al. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 15, e538\u2013e548 (2014).","journal-title":"Lancet Oncol."},{"key":"11676_CR2","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/ajh.25791","volume":"95","author":"SV Rajkumar","year":"2020","unstructured":"Rajkumar, S. V. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am. J. Hematol. 95, 548\u2013567. https:\/\/doi.org\/10.1002\/ajh.25791 (2020).","journal-title":"Am. J. Hematol."},{"key":"11676_CR3","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.mayocp.2013.01.019","volume":"88","author":"JR Mikhael","year":"2013","unstructured":"Mikhael, J. R. et al. Management of newly diagnosed symptomatic multiple myeloma: Updated mayo stratification of myeloma and risk-adapted therapy (mSMART) consensus guidelines 2013. Mayo Clin. Proc. 88, 360\u2013376. https:\/\/doi.org\/10.1016\/j.mayocp.2013.01.019 (2013).","journal-title":"Mayo Clin. Proc."},{"key":"11676_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/ijlh.12882","volume":"41","author":"D Saxe","year":"2019","unstructured":"Saxe, D., Seo, E.-J., Bergeron, M. B. & Han, J.-Y. Recent advances in cytogenetic characterization of multiple myeloma. Int. J. Lab. Hematol. 41, 5\u201314. https:\/\/doi.org\/10.1111\/ijlh.12882 (2019).","journal-title":"Int. J. Lab. Hematol."},{"key":"11676_CR5","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3324\/haematol.2011.056176","volume":"97","author":"FM Ross","year":"2012","unstructured":"Ross, F. M. et al. Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders. Haematologica 97, 1272\u20131277. https:\/\/doi.org\/10.3324\/haematol.2011.056176 (2012).","journal-title":"Haematologica"},{"key":"11676_CR6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3892\/ol.2014.2750","volume":"9","author":"N Liu","year":"2015","unstructured":"Liu, N. et al. Retrospective analysis of genetic abnormalities and survival in 131 patients with multiple myeloma. Oncol. Lett. 9, 930\u2013936 (2015).","journal-title":"Oncol. Lett."},{"key":"11676_CR7","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1007\/s12032-011-9988-7","volume":"29","author":"X Gao","year":"2012","unstructured":"Gao, X. et al. Fluorescence in situ hybridization analysis of chromosome aberrations in 60 Chinese patients with multiple myeloma. Med. Oncol. 29, 2200\u20132206 (2012).","journal-title":"Med. Oncol."},{"key":"11676_CR8","doi-asserted-by":"crossref","unstructured":"Jian, Y. et al. Prognostic impact of cytogenetic abnormalities in multiple myeloma: a retrospective analysis of 229 patients. Medicine 95 (2016).","DOI":"10.1097\/MD.0000000000003521"},{"key":"11676_CR9","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1158\/1078-0432.ccr-10-1066","volume":"17","author":"L Lopez-Corral","year":"2011","unstructured":"Lopez-Corral, L. et al. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells. Clin. Cancer Res. 17, 1692\u20131700. https:\/\/doi.org\/10.1158\/1078-0432.ccr-10-1066 (2011).","journal-title":"Clin. Cancer Res."},{"key":"11676_CR10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/gcc.22074","volume":"52","author":"D Alpar","year":"2013","unstructured":"Alpar, D. et al. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma. Genes Chromosom. Cancer 52, 785\u2013793 (2013).","journal-title":"Genes Chromosom. Cancer"},{"key":"11676_CR11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1309\/AJCPF7NFLW8UAJEP","volume":"136","author":"L Hartmann","year":"2011","unstructured":"Hartmann, L. et al. Detection of genomic abnormalities in multiple myeloma: The application of FISH analysis in combination with various plasma cell enrichment techniques. Am. J. Clin. Pathol. 136, 712\u2013720 (2011).","journal-title":"Am. J. Clin. Pathol."},{"key":"11676_CR12","first-page":"646","volume":"7","author":"K Weber-Matthiesen","year":"1993","unstructured":"Weber-Matthiesen, K., Pressl, S., Schlegelberger, B. & Grote, W. Combined immunophenotyping and interphase cytogenetics on cryostat sections by the new FICTION method. Leukemia 7, 646\u2013649 (1993).","journal-title":"Leukemia"},{"key":"11676_CR13","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3343\/alm.2018.38.3.196","volume":"38","author":"HA Jung","year":"2018","unstructured":"Jung, H. A., Jang, M.-A., Kim, K. & Kim, S.-H. Clinical utility of a diagnostic approach to detect genetic abnormalities in multiple myeloma: A single institution experience. Ann. Lab. Med. 38, 196\u2013203. https:\/\/doi.org\/10.3343\/alm.2018.38.3.196 (2018).","journal-title":"Ann. Lab. Med."},{"key":"11676_CR14","doi-asserted-by":"publisher","unstructured":"Segges, P. et al. Genetic aberrations in multiple myeloma characterized by cIg-FISH: A Brazilian context. https:\/\/doi.org\/10.1590\/1414-431x20155034 (2016).","DOI":"10.1590\/1414-431x20155034"},{"key":"11676_CR15","first-page":"226","volume":"32","author":"D Wang","year":"2011","unstructured":"Wang, D. et al. Application of FICTION technique to the detection of genetic aberrations in multiple myeloma. Zhonghua Xue Ye Xue Za Zhi 32, 226\u2013230 (2011).","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"11676_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s12185-010-0651-4","volume":"92","author":"J Cumova","year":"2010","unstructured":"Cumova, J. et al. Optimization of immunomagnetic selection of myeloma cells from bone marrow using magnetic activated cell sorting. Int. J. Hematol. 92, 314\u2013319. https:\/\/doi.org\/10.1007\/s12185-010-0651-4 (2010).","journal-title":"Int. J. Hematol."},{"key":"11676_CR17","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1309\/ajcpf7nflw8uajep","volume":"136","author":"L Hartmann","year":"2011","unstructured":"Hartmann, L. et al. Detection of genomic abnormalities in multiple myeloma. Am. J. Clin. Pathol. 136, 712\u2013720. https:\/\/doi.org\/10.1309\/ajcpf7nflw8uajep (2011).","journal-title":"Am. J. Clin. Pathol."},{"key":"11676_CR18","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3324\/haematol.2011.060632","volume":"98","author":"M Schmidt-Hieber","year":"2013","unstructured":"Schmidt-Hieber, M. et al. Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: A study in highly purified aberrant plasma cells. Haematologica 98, 279\u2013287. https:\/\/doi.org\/10.3324\/haematol.2011.060632 (2013).","journal-title":"Haematologica"},{"key":"11676_CR19","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","volume":"23","author":"PR Greipp","year":"2005","unstructured":"Greipp, P. R. et al. International staging system for multiple myeloma. J. Clin. Oncol. 23, 3412\u20133420 (2005).","journal-title":"J. Clin. Oncol."},{"key":"11676_CR20","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/jco.2015.61.2267","volume":"33","author":"A Palumbo","year":"2015","unstructured":"Palumbo, A. et al. Revised international staging system for multiple myeloma: A report from international myeloma working group. J. Clin. Oncol. 33, 2863\u20132869. https:\/\/doi.org\/10.1200\/jco.2015.61.2267 (2015).","journal-title":"J. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11676-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11676-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11676-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:55:43Z","timestamp":1669344943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-11676-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["11676"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-11676-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"assertion":[{"value":"9 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8287"}}